PAREXEL Reports Third Quarter Fiscal Year 2009 Financial Results

- Consolidated service revenue of $264.5 million grows 7.8% year-over-year
- Operating margin of 10.0%, Diluted earnings per share of $0.25
- Net quarterly book-to-bill ratio equates to 1.25

PAREXEL International Corporation (Nasdaq: PRXL) today announced its financial results for the third quarter ended March 31, 2009.

For the three months ended March 31, 2009, PAREXEL's consolidated service revenue increased 7.8% to $264.5 million, compared with $245.3 million in the prior year period. Foreign exchange negatively impacted the quarter by $35.7 million dollars.

SXC Health solutions announces strong fourth quarter and year end financial results

<< - Accretive acquisition of NMHC drives GAAP earnings per share growth - Adjusted EBITDA $14.7 million in Q4 2008, up from $6.5 million in Q4 2007 >>

SXC Health Solutions Corp. ("SXC" or the "Company") (NASDAQ: SXCI, TSX: SXC), announces its financial results for the three- and twelve-month periods ended December 31, 2008. Financial references are in U.S. dollars unless otherwise indicated.

"2008 was a very rewarding year for SXC in which we delivered strong financial performance and built the platform to drive future growth," said Mark Thierer, President and CEO of SXC. "We made two strategic acquisitions, won substantial contracts in several target markets, added strong leadership in multiple areas of the business and grew the Company's reputation for technology innovation.

WebMD Announces Fourth Quarter Financial Results

Total Revenue Increased 15%; Online Ad Revenue Increased 21%

WebMD Achieves Record Traffic with 54 Million Unique Monthly Users and 1.3 Billion Quarterly Page Views

WebMD Health Corp. (Nasdaq: WBMD) today announced financial results for the three months ended December 31, 2008.

"Our fourth quarter results confirm WebMD's market leadership in a challenging business environment. The size and breadth of the overall market opportunity for WebMD remains unchanged," said Wayne Gattinella, President and CEO. "We remain confident in our ability to continue to deliver strong results over the long term."

Technology Solutions Company Announces Approval of Plan of Liquidation and Dissolution by Board of Directors

Technology Solutions Company (NASDAQ: TSCC), a software and services company focused on the healthcare provider market, today announced that its Board of Directors has determined, after extensive and careful consideration of the Company’s strategic alternatives and analysis of the prevailing economic and industry conditions, that it is in the best interests of the Company and its stockholders to liquidate the Company's assets and to dissolve the Company. The Company's Board of Directors has approved a Plan of Complete Liquidation and Dissolution of the Company (the "Plan"), subject to stockholder approval.